久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China approves first domestically produced nine-valent HPV vaccine

Xinhua | Updated: 2025-05-30 16:14
Share
Share - WeChat

XIAMEN -- China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the National Medical Products Administration.

The vaccine, Cecolin 9, was jointly developed by the Xiang An Biomedicine Laboratory, Xiamen University and Wantai BioPharm. Its approval makes China the second country in the world — after the United States — with the capability to independently supply high-valency HPV vaccines.

Since 2019, the vaccine has been through five clinical trials conducted across China, involving more than 11,000 healthy volunteers aged nine to 45.

Results from these trials showed that the vaccine provides strong protection against HPV types 16 and 18 — the same strains covered by the two-valent vaccine — as well as five other HPV types 31, 33, 45, 52 and 58, with a protection rate of over 98 percent against persistent infections lasting more than 12 months and a 100 percent protection rate against cervical infections.

For girls aged nine to 17, just two doses are sufficient to produce an immune response comparable to that seen in women aged 18 to 26 who receive three doses. For girls aged 15 to 17, it is currently the only two-dose HPV vaccine available in China.

A comparative study showed that the new vaccine offers immune responses comparable with similar international products for at least 30 months after full immunization. These findings have been published in The Lancet Infectious Diseases.

The new vaccine is the latest achievement from the research team that also developed China's first domestically made two-valent HPV vaccine in 2019. In 2021, the two-valent HPV vaccine received prequalification from the World Health Organization (WHO) and has since entered the markets of 21 countries.

Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. China made free HPV vaccination accessible to approximately 40 percent of girls aged 13 to 14 in 2024, as part of its ongoing work to tackle cervical cancer, according to the National Health Commission.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 91四虎国自产在线播放线 | 成年人免费网站在线观看 | 国产一区亚洲二区三区毛片 | 老司机午夜精品网站在线观看 | 国产一区二区三区免费播放 | 草草国产成人免费视频 | 欧美成人看片一区二区三区 | 毛片图片 | a一级毛片免费高清在线 | 欧美高清videossex19 | 亚洲系列中文字幕一区二区 | 毛片手机在线 | 亚洲成人三级 | 亚洲自拍图片区 | 玖草在线视频 | a级淫片 | 中美日韩在线网免费毛片视频 | 日韩三级黄色 | 国产免费成人在线视频 | 玖草在线观看 | 亚洲国产精品乱码在线观看97 | 欧美黑大粗硬毛片视频 | 欧美亚洲激情视频 | 美女美女大片黄a大片 | 亚洲欧美一区二区三区四区 | 欧美日韩一区在线观看 | www亚洲免费| 我想看三级特黄 | 美女网站免费观看视频 | 国产视频亚洲 | 久草视频中文在线 | 萌白酱福利视频在线网站 | 欧美俄罗斯一级毛片激情 | 日韩欧美在线综合网高清 | 日本不卡免费高清视频 | 国产精品日韩 | 一本伊大人香蕉高清在线观看 | 99国产福利视频区 | 福利社在线 | 精品国产91久久久久久久 | 99精品视频在线播放2 |